161 related articles for article (PubMed ID: 30583830)
1. [2018 Consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary].
Matías-Guiu X; Fusté V; Iglesias L; Balañá C; Concha Á; de la Cruz-Merino L; Nieto B; Pané M; Sanz J; Losa F
Rev Esp Patol; 2019; 52(1):33-44. PubMed ID: 30583830
[TBL] [Abstract][Full Text] [Related]
2. 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary.
Losa F; Iglesias L; Pané M; Sanz J; Nieto B; Fusté V; de la Cruz-Merino L; Concha Á; Balañá C; Matías-Guiu X
Clin Transl Oncol; 2018 Nov; 20(11):1361-1372. PubMed ID: 29808414
[TBL] [Abstract][Full Text] [Related]
3. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
García-Alfonso P; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; Ramón Y Cajal S; Hernández-Losa J; Landolfi S; Musulén E; Cuatrecasas M; Navarro S
Clin Transl Oncol; 2020 Nov; 22(11):1976-1991. PubMed ID: 32418154
[TBL] [Abstract][Full Text] [Related]
4. [Liquid biopsy in oncology: A consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Álvarez-Alegret R; Rojo Todo F; Garrido P; Bellosillo B; Rodríguez-Lescure Á; Rodríguez-Peralto JL; Vera R; de Álava E; García-Campelo R; Remon J
Rev Esp Patol; 2020; 53(4):234-245. PubMed ID: 33012494
[TBL] [Abstract][Full Text] [Related]
5. [Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Palacios Calvo J; Albanell J; Rojo F; Ciruelos E; Aranda-López I; Cortés J; García-Caballero T; Martín M; López-García MÁ; Colomer R
Rev Esp Patol; 2018; 51(2):97-109. PubMed ID: 29602380
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
García-Alfonso P; Salazar R; García-Foncillas J; Musulén E; García-Carbonero R; Payá A; Pérez-Segura P; Ramón y Cajal S; Navarro S; ;
Clin Transl Oncol; 2012 Oct; 14(10):726-39. PubMed ID: 22855150
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Pérez JMT; García-Cosío M; García-Castaño A; Gomà M; Mesia-Nin R; Ruiz-Bravo E; Soria-Rivas A; Castillo P; Braña-García I; Alberola-Ferranti M
Rev Esp Patol; 2023; 56(1):45-57. PubMed ID: 36599600
[TBL] [Abstract][Full Text] [Related]
8. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
Vera R; Ibarrola-de Andrés C; Adeva J; Pérez-Rojas J; García-Alfonso P; Rodríguez-Gil Y; Macarulla T; Serrano-Piñol T; Mondéjar R; Madrigal-Rubiales B
Rev Esp Patol; 2023; 56(1):32-44. PubMed ID: 36599598
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Trigo J; García-Cosío M; García-Castaño A; Gomà M; Mesia-Nin R; Ruiz-Bravo E; Soria-Rivas A; Castillo P; Braña-García I; Alberola-Ferranti M
Clin Transl Oncol; 2022 Oct; 24(10):1890-1902. PubMed ID: 35739348
[TBL] [Abstract][Full Text] [Related]
10. Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Felip E; Concha Á; de Castro J; Gómez-Román J; Garrido P; Ramírez J; Isla D; Sanz J; Paz-Ares L; López-Ríos F
Clin Transl Oncol; 2015 Feb; 17(2):103-12. PubMed ID: 25351175
[TBL] [Abstract][Full Text] [Related]
11. Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?
Olivier T; Fernandez E; Labidi-Galy I; Dietrich PY; Rodriguez-Bravo V; Baciarello G; Fizazi K; Patrikidou A
Cancer Treat Rev; 2021 Jun; 97():102204. PubMed ID: 33866225
[TBL] [Abstract][Full Text] [Related]
12. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.
Yan N; Zhang Y; Guo X; Yuan D; Tian G; Yang J
Methods Mol Biol; 2020; 2204():109-119. PubMed ID: 32710319
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary.
El Rassy E; Khaled H; Pavlidis N
Eur J Cancer; 2018 Dec; 105():28-32. PubMed ID: 30388661
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
15. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
Vera R; Ibarrola-de-Andrés C; Adeva J; Pérez-Rojas J; García-Alfonso P; Rodríguez-Gil Y; Macarulla T; Serrano-Piñol T; Mondéjar R; Madrigal-Rubiales B
Clin Transl Oncol; 2022 Nov; 24(11):2107-2119. PubMed ID: 36008616
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Remon J; García-Campelo R; de Álava E; Vera R; Rodríguez-Peralto JL; Rodríguez-Lescure Á; Bellosillo B; Garrido P; Rojo F; Álvarez-Alegret R
Clin Transl Oncol; 2020 Jun; 22(6):823-834. PubMed ID: 31559582
[TBL] [Abstract][Full Text] [Related]
17. [Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Oaknin A; Guarch R; Barretina P; Hardisson D; González-Martín A; Matías-Guiu X; Pérez-Fidalgo A; Vieites B; Romero I; Palacios J
Rev Esp Patol; 2018; 51(2):84-96. PubMed ID: 29602379
[TBL] [Abstract][Full Text] [Related]
18. Recommendations on the pathological report of pituitary tumors. A consensus of experts of the Spanish Society of Endocrinology and Nutrition and the Spanish Society of Pathology.
Picó A; Aranda-López I; Sesmilo G; Toldos-González Ó; Japón MA; Luque RM; Puig-Domingo M
Endocrinol Diabetes Nutr (Engl Ed); 2021 Mar; 68(3):196-207. PubMed ID: 34167699
[TBL] [Abstract][Full Text] [Related]
19. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.
Cong WM; Bu H; Chen J; Dong H; Zhu YY; Feng LH; Chen J;
World J Gastroenterol; 2016 Nov; 22(42):9279-9287. PubMed ID: 27895416
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Colomer R; Aranda-López I; Albanell J; García-Caballero T; Ciruelos E; López-García MÁ; Cortés J; Rojo F; Martín M; Palacios-Calvo J
Clin Transl Oncol; 2018 Jul; 20(7):815-826. PubMed ID: 29273958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
